大佛药业 (836649.OC)

+ 收藏

现金流量表(大佛药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 173,327,971.81246,487,634.89136,291,154.26272,367,749.17133,119,075.91
 收到的税费返还(元) 11,198.07-6,860.902,053,478.91-
 收到其他与经营活动有关的现金(元) 6,101,600.073,305,957.589,610,968.718,255,825.409,798,531.66
 经营活动现金流入小计(元) 179,440,769.95249,793,592.47145,908,983.87282,677,053.48142,917,607.57
 购买商品、接受劳务支付的现金(元) 114,692,287.2759,614,297.7939,530,495.0621,635,798.1410,635,895.04
 支付给职工以及为职工支付的现金(元) 18,764,114.5123,601,728.0712,764,086.9919,484,461.5810,321,427.21
 支付的各项税费(元) 6,673,108.2738,740,546.8435,598,705.1629,773,636.7511,140,442.75
 支付其他与经营活动有关的现金(元) 70,452,382.16152,417,136.85108,218,823.46157,121,475.9685,429,933.09
 经营活动现金流出小计(元) 210,581,892.21274,373,709.55196,112,110.67228,015,372.43117,527,698.09
 经营活动产生的现金流量净额(元) -31,141,122.26-24,580,117.08-50,203,126.8054,661,681.0525,389,909.48
二、投资活动产生的现金流量
 收回投资收到的现金(元) -170,630,123.29170,000,000.0060,268,273.9740,268,273.97
 处置固定资产、无形资产和其他长期资产收回的现金净额(元) -5,120.00---
 投资活动现金流入小计(元) -170,635,243.29170,000,000.0060,268,273.9740,268,273.97
 购建固定资产、无形资产和其他长期资产支付的现金(元) 499,177.0165,209,855.2630,265.49683,613.42-
 投资支付的现金(元) -700,000.0048,546,000.00110,000,000.0040,000,000.00
 投资活动现金流出小计(元) 499,177.0165,909,855.2648,576,265.49110,683,613.4240,000,000.00
 投资活动产生的现金流量净额(元) -499,177.01104,725,388.03121,423,734.51-50,415,339.45268,273.97
三、筹资活动产生的现金流量
 取得借款收到的现金(元) 13,000,000.00----
 收到其他与筹资活动有关的现金(元) 29,545,020.56----
 筹资活动现金流入小计(元) 42,545,020.56----
 分配股利、利润或偿付利息支付的现金(元) 145,666.6666,445,000.0050,690,000.0027,400,000.0027,400,000.00
 支付其他与筹资活动有关的现金(元) 5,239,403.8632,185,368.71782,797.731,325,136.67905,818.73
 筹资活动现金流出小计(元) 5,385,070.5298,630,368.7151,472,797.7328,725,136.6728,305,818.73
 筹资活动产生的现金流量净额(元) 37,159,950.04-98,630,368.71-51,472,797.73-28,725,136.67-28,305,818.73
五、现金及现金等价物净增加额(元) 5,519,650.77-18,485,097.7619,747,809.98-24,478,795.07-2,647,635.28
 加:期初现金及现金等价物余额(元) 23,652,501.1542,137,598.9142,137,598.9166,616,393.9866,616,393.98
 期末现金及现金等价物余额(元) 29,172,151.9223,652,501.1561,885,408.8942,137,598.9163,968,758.70
补充资料:
 净利润(元) 10,419,080.0931,245,284.9116,118,399.6738,465,919.4215,221,968.34
 资产减值准备(元) -213,327.16-654,009.61-807,998.761,414,818.77-413,890.40
 固定资产和投资性房地产折旧(元) 499,899.93958,673.05468,018.07908,793.96454,582.96
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) 499,899.93958,673.05468,018.07908,793.96454,582.96
 无形资产摊销(元) 935,245.98212,658.5717,579.2844,131.6926,552.41
 长期待摊费用摊销(元) 1,358,397.571,470,448.05680,192.581,360,385.16680,192.58
 处置固定资产、无形资产和其他长期资产的损失(元) -26,211.05--6,486.97-4,388.90
 财务费用(元) 67,246.43186,944.69107,307.47288,476.46151,364.26
 投资损失(元) -68,377.8371,642.01--268,273.97-268,273.97
 递延所得税(元) -389,774.494,740,306.09-5,162,140.05-1,277,031.36-1,345,379.01
  其中:递延所得税资产减少(元) -389,774.494,740,306.09-5,162,140.05-1,277,031.36-1,345,379.01
 存货的减少(元) 268,496.00-6,327,890.68-3,616,923.66169,869.91-1,057,724.63
 经营性应收项目的减少(元) 21,334,183.08-32,966,615.91-77,501,431.67-5,115,747.981,408,941.46
 经营性应付项目的增加(元) -67,308,904.42-26,021,641.1318,150,464.8915,857,373.319,231,024.09
 其他(元) --236,665.64---
 现金的期末余额(元) 29,172,151.9223,652,501.1561,885,408.8942,137,598.9163,968,758.70
 减:现金的期初余额(元) 23,652,501.1542,137,598.9142,137,598.9166,616,393.9866,616,393.98
 现金及现金等价物的净增加额(元) 5,519,650.77-18,485,097.7619,747,809.98-24,478,795.07-2,647,635.28
公告日期 2024-08-282024-04-262023-08-142023-04-142022-08-22
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院